# McGraw Hill, Inc.: financial statements, quarterly

MH · NYSE · CIK 1951070 · [Communication](/sectors/communication.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/mh.md) · [Financials](/companies/mh/financials.md) · [Filings](/companies/mh/filings.md) · [Insiders](/companies/mh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mh/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [523](/filings/0001628280-25-040280.md) | [689](/filings/0001951070-25-000009.md) | [416](/filings/0001951070-26-000011.md) | [473 d](/filings/0001951070-26-000022.md) | [536](/filings/0001951070-26-000039.md) | [669](/filings/0001951070-25-000009.md) | [434](/filings/0001951070-26-000011.md) | [464 d](/filings/0001951070-26-000022.md) | [550](/filings/0001951070-26-000039.md) |
| Gross profit | $m | [398](/filings/0001628280-25-040280.md) | [535](/filings/0001951070-25-000009.md) | [351](/filings/0001951070-26-000011.md) | [395 d](/filings/0001951070-26-000022.md) | [412](/filings/0001951070-26-000039.md) | [530](/filings/0001951070-25-000009.md) | [370](/filings/0001951070-26-000011.md) | [389 d](/filings/0001951070-26-000022.md) | [439](/filings/0001951070-26-000039.md) |
| Research and development | $m | [63.5](/filings/0001628280-25-040280.md) | [63.5](/filings/0001951070-25-000009.md) | [70.1](/filings/0001951070-26-000011.md) | [87.4 d](/filings/0001951070-26-000022.md) | [65.5](/filings/0001951070-26-000039.md) | [69.7](/filings/0001951070-25-000009.md) | [67.5](/filings/0001951070-26-000011.md) | [73.6 d](/filings/0001951070-26-000022.md) | [59.8](/filings/0001951070-26-000039.md) |
| Operating income | $m | [75.8](/filings/0001628280-25-040280.md) | [179](/filings/0001951070-25-000009.md) | [24.2](/filings/0001951070-26-000011.md) | [27.8 d](/filings/0001951070-26-000022.md) | [96.2](/filings/0001951070-26-000039.md) | [157](/filings/0001951070-25-000009.md) | [30.4](/filings/0001951070-26-000011.md) | [(6.4) d](/filings/0001951070-26-000022.md) | [114](/filings/0001951070-26-000039.md) |
| Income tax | $m | [4.4](/filings/0001628280-25-040280.md) | [(37.2)](/filings/0001951070-25-000009.md) | [8.2](/filings/0001951070-26-000011.md) | [121 d](/filings/0001951070-26-000022.md) | [36.9](/filings/0001951070-26-000039.md) | [(21.1)](/filings/0001951070-25-000009.md) | [(5.0)](/filings/0001951070-26-000011.md) | [(2.5) d](/filings/0001951070-26-000022.md) | [10.7](/filings/0001951070-26-000039.md) |
| Net income | $m | [(9.4)](/filings/0001951070-26-000011.md) | [133](/filings/0001951070-26-000011.md) | [(52.9)](/filings/0001951070-26-000011.md) | [(157) d](/filings/0001951070-26-000022.md) | [0.5](/filings/0001951070-26-000039.md) | [105](/filings/0001951070-26-000011.md) | [(20.2)](/filings/0001951070-26-000011.md) | [(50.3) d](/filings/0001951070-26-000022.md) | [57.9](/filings/0001951070-26-000039.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001628280-25-040280.md) | [0.80](/filings/0001951070-25-000009.md) | [(0.32)](/filings/0001951070-26-000011.md) | not reported | [0.00](/filings/0001951070-26-000039.md) | [0.57](/filings/0001951070-25-000009.md) | [(0.11)](/filings/0001951070-26-000011.md) | not reported | [0.30](/filings/0001951070-26-000039.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0001628280-25-040280.md) | [0.80](/filings/0001951070-25-000009.md) | [(0.32)](/filings/0001951070-26-000011.md) | not reported | [0.00](/filings/0001951070-26-000039.md) | [0.57](/filings/0001951070-25-000009.md) | [(0.11)](/filings/0001951070-26-000011.md) | not reported | [0.30](/filings/0001951070-26-000039.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [390](/filings/0001951070-26-000022.md) | [247](/filings/0001628280-25-040280.md) | [463](/filings/0001951070-25-000009.md) | [514](/filings/0001951070-26-000011.md) | [254](/filings/0001951070-26-000039.md) | [194](/filings/0001951070-26-000039.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [1,053](/filings/0001951070-26-000022.md) | [992](/filings/0001628280-25-040280.md) | [1,424](/filings/0001951070-25-000009.md) | [1,069](/filings/0001951070-26-000011.md) | [974](/filings/0001951070-26-000039.md) | [888](/filings/0001951070-26-000039.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [5,758](/filings/0001951070-26-000022.md) | [5,661](/filings/0001628280-25-040280.md) | [6,045](/filings/0001951070-25-000009.md) | [5,644](/filings/0001951070-26-000011.md) | [5,486](/filings/0001951070-26-000039.md) | [5,379](/filings/0001951070-26-000039.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [1,330](/filings/0001951070-26-000022.md) | [1,199](/filings/0001628280-25-040280.md) | [1,410](/filings/0001951070-25-000009.md) | [1,282](/filings/0001951070-26-000011.md) | [1,267](/filings/0001951070-26-000039.md) | [1,145](/filings/0001951070-26-000039.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [5,478](/filings/0001951070-26-000022.md) | [5,378](/filings/0001628280-25-040280.md) | [5,251](/filings/0001951070-25-000009.md) | [4,869](/filings/0001951070-26-000011.md) | [4,759](/filings/0001951070-26-000039.md) | [4,590](/filings/0001951070-26-000039.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [3,165](/filings/0001951070-26-000022.md) | [3,165](/filings/0001628280-25-040280.md) | [2,797](/filings/0001951070-25-000009.md) | [2,606](/filings/0001951070-26-000011.md) | [2,561](/filings/0001951070-26-000039.md) | [2,561](/filings/0001951070-26-000039.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [13.2](/filings/0001951070-26-000022.md) | [13.2](/filings/0001628280-25-040280.md) | [13.2](/filings/0001951070-25-000009.md) | [13.2](/filings/0001951070-26-000011.md) | [13.2](/filings/0001951070-26-000039.md) | [13.2](/filings/0001951070-26-000039.md) |
| Shareholders' equity | $m | [558](/filings/0001951070-26-000022.md) | [369](/filings/0001951070-26-000022.md) | [358](/filings/0001951070-26-000011.md) | [492](/filings/0001951070-26-000011.md) | [436](/filings/0001951070-26-000011.md) | [280](/filings/0001951070-26-000039.md) | [283](/filings/0001951070-26-000039.md) | [795](/filings/0001951070-26-000011.md) | [775](/filings/0001951070-26-000011.md) | [726](/filings/0001951070-26-000039.md) | [788](/filings/0001951070-26-000039.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.9)](/filings/0001628280-25-040280.md) | [415 d](/filings/0001951070-25-000009.md) | [275 d](/filings/0001951070-26-000011.md) | [(41.2) d](/filings/0001951070-26-000022.md) | [(96.7)](/filings/0001951070-26-000039.md) | [265 d](/filings/0001951070-25-000009.md) | [309 d](/filings/0001951070-26-000011.md) | [(146) d](/filings/0001951070-26-000022.md) | [0.6](/filings/0001951070-26-000039.md) |
| Capital expenditure | $m | [15.9](/filings/0001628280-25-040280.md) | [13.1 d](/filings/0001951070-25-000009.md) | [13.6 d](/filings/0001951070-26-000011.md) | [28.4 d](/filings/0001951070-26-000022.md) | [16.3](/filings/0001951070-26-000039.md) | [21.2 d](/filings/0001951070-25-000009.md) | [23.6 d](/filings/0001951070-26-000011.md) | [23.8 d](/filings/0001951070-26-000022.md) | [23.9](/filings/0001951070-26-000039.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [167](/filings/0001628280-25-040280.md) | [167](/filings/0001951070-25-000009.md) | [167](/filings/0001951070-26-000011.md) | [167](/filings/0001951070-26-000039.md) | [186](/filings/0001951070-25-000009.md) | [191](/filings/0001951070-26-000011.md) | [191](/filings/0001951070-26-000039.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 191,308,814 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001951070-26-000039.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.